CLINICAL_TRIALS research · 2026-04-20

Clinical Trial Update: Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency [Phase 3]

This Clinical Trial Update indicates that a Phase 3 study of LUM-201 in children with Growth Hormone Deficiency is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Lumos Pharma | Conditions: Growth Hormone Deficiency (GHD) | Phase 3 | Status: RECRUITING